Organisation paid for research Program year 2023 Source: CMS Open Payments

Alternative Research Associate LLC

Neither a doctor nor a teaching hospital

Research payments

$327,993

19 payments

Through program year 2023, Alternative Research Associate LLC is reported as receiving $327,993 in research payments, across 19 payments.

By program year

2 rows
Year Kind Amount Payments
2023 Research $137,273 5
2021 Research $190,720 14

Breakdown

Who paid Research payments · program years 2021–2023
  1. GlaxoSmithKline, LLC. $136,036 3 payments
  2. Hoffmann-La Roche Limited $101,155 2 payments
  3. Genentech, Inc. $90,802 14 payments
Studies the money was for Research payments · program years 2021–2023
  1. A Phase 3, Open-Label, Randomized, Controlled, Multi Country Study to $136,036 3 payments
  2. Safety Efficacy of A Combination of Remdesivir Tocilizumab in Severe Covid 19 Pneumonia $101,155 2 payments
  3. Tocilizumab Therapy for Covid 19 Pneumonia in Hospitalized Patients $90,802 14 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record